Maze Therapeutics reports positive Phase 2 data for MZE829 in patients with AMKD

Andel launches new direct-to-employer medication platform for GLP-1s

Dexcom highlights new diabetes outcomes and product roadmap at ATTD 2026

Cedar Health Research opens new embedded research site within Texas Native Health

AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC

Alvotech reaches global settlement over aflibercept biosimilar patents

MedPal AI announces approval to supply Eli Lilly medicines in UK

Hanmi Pharmaceutical signs distribution agreement with Laboratorios Sanfer in Mexico

Viking Therapeutics publishes Phase 2 data showing up to 14.7% weight loss with VK2735

NewcelX reports positive biomaterial study results supporting stem cell islet delivery without immune suppression

Sanofi's Teizeild approved in EU to delay stage 3 type 1 diabetes

Renalytix expands US clinical footprint with three kidneyintelX.dkd integrations

GSK wins European Commission approval for Shingrix prefilled syringe

Abbott launches Libre Assist for in-the-moment food decisions

RedHill advances RHB-102 across GI indications